Delivery Order SPE2DB20D2104-SPE2DB24FV68P

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.11 firm fixed-price delivery order is for the supply of DULERA 200 MCG-5 MCG INHALER 13GM medical products. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Dulera 100 mcg-5 mcg inhalers to the Defense Logistics Agency (DLA). The $4,678.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc. The contract has an ultimate completion date of February 23, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.29 firm fixed price delivery order is for the supply of DULERA 100 MCG-5 MCG INHALER 13GM, a medical product used for respiratory treatments. The contract has an ultimate completion date of April 13, 2023 and was awarded on April 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.60 firm fixed-price delivery order is for the supply of Dulera 200 mcg-5 mcg inhalers, a medication used to treat asthma. The contract has an ultimate completion date of January 31, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,185.58 fixed-price delivery order is for the supply of DULERA 100 MCG-5 MCG INHALER 13GM, a respiratory medication. The contract has an ultimate completion date of March 28, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,333.84 firm fixed-price delivery order is for the supply of DULERA 100 MCG-5 MCG INHALER 13GM, a medication used for the treatment of asthma. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp. The $2,657.74 firm-fixed-price delivery order is for the supply of DULERA 200 MCG-5 MCG INHALER 8.8GM, a prescription medication. The contract has a ceiling value of $2,657.74 and an ultimate completion date of June 14, 2024. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,224.72 Firm Fixed Price Delivery Order is for the supply of DULERA 200 MCG-5 MCG INHALER 13GM medical products, with an ultimate completion date of August 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,309.36 firm fixed-price delivery order is for the supply of DULERA 100 MCG-5 MCG INHALER 13GM, a medical product used for respiratory conditions. The contract has a period of performance through May 17, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of Dulera 100 mcg-5 mcg inhalers. The contract, valued at $1,248.84, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceutical...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV68P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,248.09 firm fixed-price delivery order is for the supply of Dulera 100 mcg-5 mcg inhalers. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award was not set aside for any specific business category.

Generated 2/27/25, 1:17 PM